Krishna Bhatta, MD
Urology · Skowhegan, MENPI 1740290618
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,506 of the $2,438 with a category attached, or 61.8%. 10 manufacturers reported payments, led by Axonics, Inc. at 49.7% of the total. Reporting peaked in 2021 at $1,118 and has fallen 61.7% since, to $428 in 2024.
Across 28 payments — averaging $87.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$1K
- Biotissue Holdings Inc.$620
- Procept Biorobotics Corporation$165
- AbbVie$157
- Olympus America Inc.$117
- Johnson & Johnson$89
- plus $77 from 4 others
What the payments were for
- Travel & lodging$91838%
- Food & beverage$1,50662%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 13 | $1,212 |
| Biotissue Holdings Inc. | 3 | $620 |
| Procept Biorobotics Corporation | 1 | $165 |
| AbbVie(2 entities) | 5 | $157 |
| Olympus America Inc. | 1 | $117 |
| Johnson & Johnson | 1 | $89 |
| Photocure Inc | 1 | $33 |
| Dentsply IH AB | 1 | $18 |
| Pfizer | 1 | $15 |
| Hologic Sales And Service, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bulkamid$722
- Axonics r-SNM System$722
- AquaBeam Robotic System$165
- iTIND System$117
- Prokera$110
- AmnioGraft$110
- Axonics$106
How this compares
$2,438 in reported general payments places this provider in the 75th percentile of 59 urology providers in Maine.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 177 | $2,703 |
| Potassium Citrate ErPotassium Citrate | 11 | $2,186 |
| Oxybutynin Chloride ErOxybutynin Chloride | 48 | $1,050 |
| Finasteride | 41 | $426 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 14 | $404 |
| Ciprofloxacin Hcl | 23 | $132 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $117 |
Paid to pharmacies, not to this prescriber.
Other urology in Skowhegan
- Griffith BatstoneFarmington$123K
- David SobelPortland$58K
- Marc HodroffPortland$17K
- Evan DunnLewiston$9K
- Robert FisherRockport$9K
- Christopher HenryLewiston$6K
- Jesse SammonSouth Portland$6K
- Sanchita BoseSouth Portland$6K
- Michael ParkerLewiston$4K
- Michelle RamirezBiddeford$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.